Development Strategy

Medinice strives to create the largest platform for researchers, scientists and innovators in the field of Cardiology and Cardio Surgery. At present Medinice’s platform has clear emphasis on cardiology but in future the same model can be rolled out to other life science sectors. The Medinice strategy focuses on three main areas of activity:

Developing own projects

The first area of activity is based on the scientific potential of the Medinice team (shareholders are, among others, professors and doctors of medical sciences), including members of the Scientific Council. The Company develops inventions developed by team members with global potential.

Developing projects together with the inventor

The second area of activity involves developing cooperation with R&D Centres and scientists. The company actively seeks new projects with POP or POC at seed stage. After reaching an agreement with the inventors, Medinice provides smart money, responsible for the business and organization development and support the inventor refine the concept.

Providing consultancy services in the field of commercialization of research and development result

The third activity area of Medinice includes the provision of advisory services in the field of commercialization of research and development products. Using the knowledge and experience of the team, the Company will provide services to the third parties.

Education

Medinice is planning to create a large-scale training programme for R&D Centres and facilities, researchers and inventors. The scope includes, among others, intellectual property management, product certification schedule, principles of commercialization of projects. The aim of the programme is to raise awareness among scientists & researchers about the road map for the commercialization of projects and to realize, that this is a comprehensive process requiring the involvement of individuals with a variety of competencies. At the same time, the company wants to create a Medinice as a brand to look for R&D support and commercialization of new technology in the fields of life sciences.

Research

Medinice has a very strong scientific board which includes academic professors and business leaders with a proven track record. Thus Medinice can support the new concepts brought and developed by innovators. Apart from that, Medinice plans to establish close cooperation with selected research and development Centres, which are working on new prototypes and with whom new inventions will be jointly developed. Based on the rich network, Medinice helps scientists & researchers in partnering and outsourcing with other entities which increases the chances of successful deployment of the product.

Commercialization

The key source of the Company’s revenues will be the commercialization of solutions. The Medinice team has experience in capital exits and the sale of intellectual property rights. The Company has established relations with leading global manufacturers and distributors of medical products – it remains in contact with representatives of key players such as Medtronic, Abbott and Boston Scientific. Cooperation with leading players will allow the introduction of developed products not only on the Polish market, but also globally.

Value Creation

The value of Medinice projects under development is growing exponentially. After successfully completing each research phase, the likelihood of a product launch in the MedTech industry increases significantly, which increases the valuation.